Sunday, December 7, 2025

Latest

Trulieve: Analysts Expect Beat On Company Full Year Guidance

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their fourth quarter and year-end financials pre-market on March 23rd. Analysts have a consensus C$65.83 12-month price target on the company, via a total of 14 analysts, with two analysts have strong buy ratings and the other 12 have buy ratings. The street high comes from Stifel-GMP with a C$107 price target, and the lowest target comes from Echelon Wealth with a C$43 price target.

Twelve analysts have revenue estimates for the fourth quarter. The mean between all 12 is U$162.49 million; this number has been revised upwards from U$159.35 million at the start of the year. Stifel-GMP currently has the highest revenue estimate with U$170.87 million, while the lowest comes from PI Financial with a U$153.25 estimate.

For the full year, management has guided for revenues between U$465 – U$485 million, but the average estimate between 14 analysts is currently U$513.59 million. This number has been revised upwards from U$511.55 million at the start of the year. The street high comes from Stifel-GMP with a U$523.95 full-year revenue estimate.

Onto EBITDA estimates, there are currently 12 analysts who have fourth-quarter EBITDA estimates. The mean is currently U$75.56 million, with this number being revised upwards from U$72.46 million at the start of the year. Street high goes to Needham with a U$81.30 million EBITDA estimate and the lowest being PI Financial with a U$68.87 million estimate.

For the full-year management has also provided guidance for EBITDA in the range of U$205 – U$225 million. The current EBITDA means across 13 analysts is U$252.47 million, with that number basically staying flat year-to-date. Needham currently has the highest full-year estimate at U$258.80 million.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Guanajuato Silver: Q3 Results Overshadowed By Silver Ripping

I Went to See the Highest Grade Silver on Earth | Nord Precious Metals

DPM Metals: Discovery To Feasibility In 36 Months!

Recommended

Emerita Resources Awards Contract For Pre-Feasibility Study On Iberian Belt West Project

Selkirk Copper Appoints Two Members Of Selkirk First Nation To Leadership Team

Related News

US Cannabis: The Current Landscape

Welcome to the Deep Dive Video Essay Series. Today we are looking at US Cannabis....

Saturday, March 6, 2021, 09:00:00 AM

Trulieve Reports Q1 Revenues of $96.1 Million, Net Income of $14.0 Million

Trulieve Cannabis (CSE: TRUL) reported its first quarter 2020 financial results this morning, posting revenues...

Wednesday, May 20, 2020, 08:28:56 AM

Trulieve Loses Foreign Private Issuer Status, Must Transition To US GAAP Reporting Standards

Evidently, recent buying activity in Trulieve Cannabis Corp (CSE: TRUL) has come largely from South...

Tuesday, July 14, 2020, 09:16:53 AM

Allegations of Bribery and Corruption Plague Arizona’s Cannabis Industry

In Arizona, the burgeoning marijuana industry has found itself embroiled in a controversy that threatens...

Wednesday, September 27, 2023, 03:55:00 PM

Trulieve Cannabis Closes Acquisition Of Harvest Health

Trulieve Cannabis (CSE: TRUL) has finally completed the acquisition of Harvest Health (CSE: HARV). It...

Friday, October 1, 2021, 07:43:45 AM